Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OCS compared with EVMN: revenue, margins and what each company keeps, and the suppliers and customers both name
OCS
Oculis Holding AG
Change
Mkt cap
Revenue
Revenue
EVMN
Evommune, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
OCS
Oculis Holding AG
vs
EVMN
Evommune, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
OCS
Oculis Holding AG
Change
7.73
· pre 7.73
· delayed
Mkt cap
$463.3M
Revenue
—
EVMN
Evommune, Inc.
Change
6.72
· pre 5.98
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$217.2M
Revenue
$10M
Q3 FY25
vs
Compare
Pre-market
Nov 3 '26
delayed
OCS
Oculis Holding AG
vs
EVMN
Evommune, Inc.
7.73
pre 7.73
delayed
Price
6.72
pre 5.98
delayed
$463.3M
Mkt cap
$217.2M
—
Revenue
$10M
Q3 FY25
Change
Change
OCS
7.73
vs
EVMN
6.72
Pre-market
Nov 3 '26
delayed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only OCS
0
None
Shared
0
No disclosed counterparties: OCS.
Only EVMN
5
—
AprilBio
unlisted
supplier
—
Dermira
unlisted
supplier
—
BDO USA, P.C
unlisted
supplier
—
Hudson Page Mill Hill
unlisted
supplier
1 more · EVMN chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR